- Investing Ideas
- Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
3
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
3 companies
Abbott India
Market Cap: ₹543.8b
Operates as a pharmaceutical company in India.
500488
₹25,591.00
7D
-2.4%
1Y
-26.9%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹399.6b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,358.85
7D
1.1%
1Y
-31.8%
Sanofi India
Market Cap: ₹77.4b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹3,360.55
7D
0.4%
1Y
-45.7%